Cargando…

Pharmacokinetic Drug Interaction Between Raloxifene and Cholecalciferol in Healthy Volunteers

Osteoporosis is a common skeletal disorder, often leading to fragility fracture. Combination therapy with raloxifene, a selective estrogen receptor modulator, and cholecalciferol (vitamin D(3)) has been proposed to improve the overall efficacy and increase compliance of raloxifene therapy for postme...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hae Won, Kang, Woo Youl, Jung, Wookjae, Gwon, Mi‐Ri, Cho, Kyunghee, Lee, Backhwan, Seong, Sook Jin, Yoon, Young‐Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305550/
https://www.ncbi.nlm.nih.gov/pubmed/34984851
http://dx.doi.org/10.1002/cpdd.1062

Ejemplares similares